6TKV image
Deposition Date 2019-11-29
Release Date 2020-01-29
Last Version Date 2024-10-16
Entry Detail
PDB ID:
6TKV
Title:
Crystal structure of the human FUT8 in complex with GDP and a biantennary complex N-glycan
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.95 Å
R-Value Free:
0.21
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Alpha-(1,6)-fucosyltransferase
Gene (Uniprot):FUT8
Chain IDs:A
Chain Length:468
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Alpha-(1,6)-fucosyltransferase
Gene (Uniprot):FUT8
Chain IDs:B
Chain Length:453
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structural basis for substrate specificity and catalysis of alpha 1,6-fucosyltransferase.
Nat Commun 11 973 973 (2020)
PMID: 32080177 DOI: 10.1038/s41467-020-14794-z

Abstact

Core-fucosylation is an essential biological modification by which a fucose is transferred from GDP-β-L-fucose to the innermost N-acetylglucosamine residue of N-linked glycans. A single human enzyme α1,6-fucosyltransferase (FUT8) is the only enzyme responsible for this modification via the addition of an α-1,6-linked fucose to N-glycans. To date, the details of substrate recognition and catalysis by FUT8 remain unknown. Here, we report the crystal structure of FUT8 complexed with GDP and a biantennary complex N-glycan (G0), which provides insight into both substrate recognition and catalysis. FUT8 follows an SN2 mechanism and deploys a series of loops and an α-helix which all contribute in forming the binding site. An exosite, formed by one of these loops and an SH3 domain, is responsible for the recognition of branched sugars, making contacts specifically to the α1,3 arm GlcNAc, a feature required for catalysis. This information serves as a framework for inhibitor design, and helps to assess its potential as a therapeutic target.

Legend

Protein

Chemical

Disease

Primary Citation of related structures